These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21265874)

  • 1. Slow-release oral morphine for opioid maintenance treatment: a systematic review.
    Jegu J; Gallini A; Soler P; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2011 Jun; 71(6):832-43. PubMed ID: 21265874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow-release oral morphine as maintenance therapy for opioid dependence.
    Ferri M; Minozzi S; Bo A; Amato L
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009879. PubMed ID: 23740540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine.
    Lehmann K; Kuhn S; Baschirotto C; Jacobsen B; Walcher S; Görne H; Backmund M; Scherbaum N; Reimer J; Verthein U
    J Subst Abuse Treat; 2021 Aug; 127():108350. PubMed ID: 34134867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.
    Beck T; Haasen C; Verthein U; Walcher S; Schuler C; Backmund M; Ruckes C; Reimer J
    Addiction; 2014 Apr; 109(4):617-26. PubMed ID: 24304412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, randomized, parallel group study to compare the efficacy, safety and tolerability of slow-release oral morphine versus methadone in opioid-dependent in-patients willing to undergo detoxification.
    Madlung-Kratzer E; Spitzer B; Brosch R; Dunkel D; Haring C
    Addiction; 2009 Sep; 104(9):1549-57. PubMed ID: 19686525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence.
    Mitchell TB; White JM; Somogyi AA; Bochner F
    Drug Alcohol Depend; 2003 Oct; 72(1):85-94. PubMed ID: 14563546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.
    Hämmig R; Köhler W; Bonorden-Kleij K; Weber B; Lebentrau K; Berthel T; Babic-Hohnjec L; Vollmert C; Höpner D; Gholami N; Verthein U; Haasen C; Reimer J; Ruckes C
    J Subst Abuse Treat; 2014 Oct; 47(4):275-81. PubMed ID: 25064422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow release oral morphine versus methadone for the treatment of opioid use disorder.
    Klimas J; Gorfinkel L; Giacomuzzi SM; Ruckes C; Socías ME; Fairbairn N; Wood E
    BMJ Open; 2019 Apr; 9(4):e025799. PubMed ID: 30944135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence.
    Mitchell TB; White JM; Somogyi AA; Bochner F
    Addiction; 2004 Aug; 99(8):940-5. PubMed ID: 15265090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): Protocol for a non-inferiority randomized clinical trial.
    Socias ME; Wood E; Dong H; Brar R; Bach P; Murphy SM; Fairbairn N
    Contemp Clin Trials; 2020 Apr; 91():105993. PubMed ID: 32194251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the impact of the slow-release oral morphine drug shortages in Ontario, Canada: A population-based time series analysis.
    Ledlie S; Tadrous M; McCormack D; Campbell T; Leece P; Kleinman RA; Kolla G; Besharah J; Smoke A; Sproule B; Gomes T
    Int J Drug Policy; 2023 Aug; 118():104119. PubMed ID: 37429161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care.
    Baschirotto C; Lehmann K; Kuhn S; Reimer J; Verthein U
    J Pharmacol Sci; 2020 Sep; 144(1):9-15. PubMed ID: 32586692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation and rapid titration of methadone and slow-release oral morphine (SROM) in an acute care, inpatient setting: a case series.
    Rodger L; Nader M; Turner S; Lurie E
    Eur J Med Res; 2023 Dec; 28(1):573. PubMed ID: 38066517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication.
    Bond AJ; Reed KD; Beavan P; Strang J
    Drug Alcohol Rev; 2012 Jun; 31(4):492-8. PubMed ID: 21919979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient Rapid Titration of Slow Release Oral Morphine for the Treatment of Opioid Use Disorder in a Canadian Setting: A Case Series.
    Brooks O; Ng JCY; Ickowicz S
    J Addict Med; 2023 Jul-Aug 01; 17(4):e240-e245. PubMed ID: 37579101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance agonist treatments for opiate-dependent pregnant women.
    Minozzi S; Amato L; Bellisario C; Ferri M; Davoli M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD006318. PubMed ID: 24366859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.
    Falcato L; Beck T; Reimer J; Verthein U
    J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials.
    Lim J; Farhat I; Douros A; Panagiotoglou D
    PLoS One; 2022; 17(3):e0266142. PubMed ID: 35358261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.